MENU
+Compare
APGE
Stock ticker: NASDAQ
AS OF
Oct 7, 04:59 PM (EDT)
Price
$39.71
Change
-$0.11 (-0.28%)
Capitalization
2.37B

APGE Apogee Therapeutics Forecast, Technical & Fundamental Analysis

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need... Show more

APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for APGE with price predictions
Oct 06, 2025

APGE's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for APGE turned positive on September 17, 2025. Looking at past instances where APGE's MACD turned positive, the stock continued to rise in of 18 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 24, 2025. You may want to consider a long position or call options on APGE as a result. In of 31 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

APGE moved above its 50-day moving average on September 26, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for APGE crossed bullishly above the 50-day moving average on September 29, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 5 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where APGE advanced for three days, in of 132 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 94 cases where APGE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where APGE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

APGE broke above its upper Bollinger Band on September 29, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.823) is normal, around the industry mean (23.464). P/E Ratio (0.000) is within average values for comparable stocks, (54.589). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.244). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (345.477).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. APGE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. APGE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

APGE is expected to report earnings to fall 46.02% to -61 cents per share on November 18

Apogee Therapeutics APGE Stock Earnings Reports
Q3'25
Est.
$-0.61
Q2'25
Missed
by $0.51
Q1'25
Missed
by $0.37
Q4'24
Missed
by $0.56
Q3'24
Missed
by $0.30
The last earnings report on August 11 showed earnings per share of -112 cents, missing the estimate of -62 cents. With 495.17K shares outstanding, the current market capitalization sits at 2.37B.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
221 Crescent Street
Phone
+1 650 394-5230
Employees
91
Web
https://www.apogeetherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EXEYX15.43N/A
N/A
Manning & Napier Equity Series S
CIVVX24.21N/A
N/A
Causeway International Value Inv
HSLRX39.44N/A
N/A
Hartford Small Cap Growth R3
GSSIX43.83N/A
N/A
Goldman Sachs Small Cap Value Inst
VGWAX34.76N/A
N/A
Vanguard Global Wellington Admiral

APGE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
-0.15%
SYRE - APGE
56%
Loosely correlated
+4.91%
DYN - APGE
51%
Loosely correlated
-3.14%
CGON - APGE
50%
Loosely correlated
-4.24%
NUVL - APGE
50%
Loosely correlated
-0.44%
IRON - APGE
49%
Loosely correlated
+2.21%
More